Name: EPRX Balance Sheet - Eupraxia Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

EPRX - Eupraxia Pharmaceuticals Inc.

USD | NASDAQ | Healthcare

EPRX Balance Sheet - Eupraxia Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	Q4 FY 25	Q4 FY 24	Q4 FY 23	Q4 FY 22	Q4 FY 21
Cash And Short Term Investments
Cash And Equivalents	80.6	33.1	19.3	18.3	-
Restricted Cash	-	-	-	-	-
Short Term Investments	-	-	-	-	-
Cash And Short Term Investments	80.6	33.1	19.3	18.3	-
Receivables
Accounts Receivable	0.7	0.3	0.2	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	3.9	1.1	0.3	0.2	-
Other Current Assets	-	-
Non-Current Assets
Property, Plant & Equipment Gross	1.5	0.8	0.8	0.7	0.6
Accumulated Depreciation	0.6	0.5	0.4	0.3	0.2
Property,Plant & Equipment Net	0.8
Current Liabilities
Accounts Payable	0.9	0.4	1.3	1.8	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	0.0	0.0	0.1	-
Deferred Revenue Non-Current	-
Common Equity
Common Stock	195.4	116.4	92.9	71.0	-
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	(169.6)	(131.0)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	79.5	31.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Cash And Short Term Investments
Cash And Equivalents	80.6	33.1	19.3	18.3	-
Restricted Cash	-	-	-	-	-
Short Term Investments	-	-	-	-	-
Cash And Short Term Investments	80.6	33.1	19.3	18.3	-
Receivables
Accounts Receivable	0.7	0.3	0.2	-	-
Current Assets
Inventory	-	-	-	-	-
Prepaid Expenses	3.9	1.1	0.3	0.2	-
Other Current Assets	-	-
Non-Current Assets
Property, Plant & Equipment Gross	1.5	0.8	0.8	0.7	0.6
Accumulated Depreciation	0.6	0.5	0.4	0.3	0.2
Property,Plant & Equipment Net	0.8
Current Liabilities
Accounts Payable	0.9	0.4	1.3	1.8	-
Short Term Debt	-	-	-	-	-
Deferred Revenue Current	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	0.0	0.0	0.1	-
Deferred Revenue Non-Current	-
Common Equity
Common Stock	195.4	116.4	92.9	71.0	-
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	(169.6)	(131.0)
Supplementary Data
Total Debt	-	-	-	-	-
Net debt	-	-	-	-	-
Working Capital	79.5	31.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)